Presence of neuropeptide Y and the Y<sub>1</sub>receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium
Danielle Jacques(Université de Sherbrooke), Magda Descorbeth(Loma Linda University), Claudine Perreault, Georges Pelletier, Alain Fournier(Institut National de la Recherche Scientifique), Sawsan Sader, Annette G. Beck‐Sickinger(Leipzig University of Applied Sciences)
Cited by 54
Related Papers
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
|Endocrinology|2006|432
Herbal drugs and phytopharmaceuticals
|Pharmaceutica Acta Helvetiae|1995|415
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
|European Journal of Pharmacology|1994|374